MARKSANS PHARMA
Smallcap | BSE
Sector
Index
Here's the live share price of Marksans Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.40₹ -2.50
As on Apr 13, 2026, 04:01 PM IST
Marksans Pharma Price Performance
Today's LowToday's High
₹171.40₹178.00
₹176.15
52 Weeks' Low52 Weeks' High
₹156.00₹270.60
₹176.15
Open Price
₹172.05
Prev. Close
₹178.65
Volume
26,726
Marksans Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Marksans Pharma | 4.76 | 1.85 | 1.94 | -0.96 | -14.30 | 34.66 | 27.25 |
| Sun Pharmaceutical Industries | -2.52 | -9.47 | -4.89 | -0.99 | -2.11 | 17.86 | 21.69 |
| Divi's Laboratories | 3.42 | -4.59 | -6.64 | -7.58 | 8.31 | 27.43 | 9.87 |
| Torrent Pharmaceuticals | 4.43 | -5.94 | 5.52 | 18.36 | 33.21 | 38.82 | 26.66 |
| Lupin | 1.73 | -1.25 | 5.77 | 17.55 | 17.63 | 51.94 | 17.24 |
| Dr. Reddy's Laboratories | 1.43 | -6.83 | 1.59 | -2.14 | 11.35 | 9.02 | 4.36 |
| Cipla | 1.50 | -8.92 | -17.38 | -22.55 | -17.21 | 10.12 | 6.05 |
| Zydus Lifesciences | 6.45 | -0.22 | 2.79 | -7.40 | 5.96 | 22.47 | 12.97 |
| Mankind Pharma | 4.10 | -7.31 | -6.63 | -14.84 | -11.57 | 13.45 | 7.86 |
| Aurobindo Pharma | 0.28 | 2.69 | 14.24 | 17.85 | 23.75 | 35.14 | 7.90 |
| Alkem Laboratories | 1.95 | -3.16 | -8.67 | -2.52 | 9.82 | 17.16 | 14.32 |
| Glenmark Pharmaceuticals | 5.07 | -3.17 | 9.03 | 15.15 | 59.74 | 65.52 | 34.59 |
| Laurus Labs | 4.19 | 4.60 | 4.38 | 24.22 | 79.50 | 53.21 | 21.19 |
| Biocon | -2.16 | -12.75 | -7.28 | -1.25 | 8.97 | 16.91 | -3.12 |
| Abbott India | -2.32 | -5.68 | -9.68 | -14.34 | -13.23 | 4.08 | 11.25 |
| Anthem Biosciences | 10.37 | 12.54 | 18.16 | -7.01 | -0.08 | -0.03 | -0.02 |
| GlaxoSmithKline Pharmaceuticals | 4.06 | -3.25 | 0.24 | -12.60 | -12.48 | 23.32 | 10.58 |
| Ipca Laboratories | -2.30 | -5.25 | -5.01 | 9.74 | 9.02 | 20.52 | 6.16 |
| Ajanta Pharma | 3.61 | -4.91 | 5.92 | 19.77 | 12.82 | 31.15 | 20.46 |
| J B Chemicals & Pharmaceuticals | 2.00 | -6.07 | 6.34 | 20.03 | 26.74 | 25.37 | 26.80 |
Over the last one year, Marksans Pharma has declined 14.30% compared to peers like Sun Pharmaceutical Industries (-2.11%), Divi's Laboratories (8.31%), Torrent Pharmaceuticals (33.21%). From a 5 year perspective, Marksans Pharma has outperformed peers relative to Sun Pharmaceutical Industries (21.69%) and Divi's Laboratories (9.87%).
Marksans Pharma Financials
Marksans Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 165.92 | 173.83 |
| 10 | 165.23 | 170.89 |
| 20 | 166.88 | 169.76 |
| 50 | 171.72 | 171.93 |
| 100 | 178.2 | 176.98 |
| 200 | 190.55 | 188.42 |
Marksans Pharma Share Holding Pattern
In the latest quarter, Marksans Pharma remained same as its previous close in promoter holding, while DII stake increased to 6.57%, FII holding rose to 16.76%, and public shareholding moved down to 32.78% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Marksans Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 33,35,509 | 0.28 | 58.01 |
* Excluding Index & Arbitrage Funds
Marksans Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Apr 09, 2026, 07:58 PM IST IST | Marksans Pharma - Compliances-Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations, 2018 |
| Apr 01, 2026, 05:42 AM IST IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Mar 11, 2026, 10:01 PM IST IST | Marksans Pharma - Intimation Regarding Opening Of Special Window For Re-Lodgment Of Transfer Requests Of Physical Shares |
| Mar 10, 2026, 10:21 PM IST IST | Marksans Pharma - Investec India Promoter & Founder Conference 2026 |
| Feb 12, 2026, 09:33 PM IST IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
About Marksans Pharma
Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24110MH1992PLC066364 and registration number is 066364. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1174.37 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address11th Floor, Grandeur, Veera Desai Extension Road, Mumbai Maharashtra 400053
- Contact
Management
- Mr. Mark SaldanhaChairman & Managing Director
- Mrs. Sandra SaldanhaWhole Time Director
- Mr. Varddhman V JainWhole Time Director
- Dr. Sunny SharmaNon Executive Director
- Mr. Srinivas MishraIndependent Director
- Mr. Digant Mahesh ParikhIndependent Director
- Mr. Abhinna Sundar MohantyIndependent Director
- Mrs. Shailaja VardhanIndependent Director
FAQs on Marksans Pharma Share Price
What is the share price of Marksans Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Marksans Pharma is ₹176.15 as on Apr 13, 2026.
What kind of stock is Marksans Pharma?
The Marksans Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Marksans Pharma?
The market cap of Marksans Pharma is ₹7,982.48 Cr as on Apr 13, 2026.
What are today's High and Low prices of Marksans Pharma?
Today’s highest and lowest price of Marksans Pharma are ₹178.00 and ₹171.40.
What are the 52 Week High and 52 Week Low of Marksans Pharma?
The 52-week high/low is the highest and lowest price at which Marksans Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Marksans Pharma is ₹270.60 and 52-week low of Marksans Pharma is ₹156.00 as on Apr 13, 2026.
How has the Marksans Pharma performed historically in terms of returns?
The Marksans Pharma has shown returns of -1.4% over the past day, 1.85% for the past month, 1.94% over 3 months, -14.3% over 1 year, 34.66% across 3 years, and 27.25% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Marksans Pharma?
P/E ratio of and PB ratio of Marksans Pharma are 22.15 and 2.85 on Apr 13, 2026. While the company gives a dividend yield of 0.45 per annum.
Marksans Pharma News
✕
Market Pulse